This site is intended for health professionals only!

Published on 2 July 2007

Share this story:

European authorisation for schizophrenia drug


The European Commission has granted marketing authorisation for the atypical antipsychotic Invega

Most read

Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Share this story: